FDA Requiring Blood Sugar Information on Statin Labels

FDA Requiring Blood Sugar Information on Statin Labels

Three areas that the FDA is raising awareness with respect to statins are: memory functioning, blood sugar elevations, and muscle damage.

Millions of people in the United States take statins in an effort to prevent heart disease. Statins are cholesterol-lowering medications; having high cholesterol is a risk factor for diabetes. However, the Food and Drug Administration (FDA) is releasing new important information on these statins from a safety standpoint.

Three areas that the FDA is raising awareness with respect to statins are: memory functioning, blood sugar elevations, and muscle damage.

The FDA will be adding warning levels relating to each of these areas as a safety precaution. For instance, the new label on statins will indicated that statins may raise blood glucose level, which then can lead to an increased risk of diabetes. Therefore, people who are taking statins should have their blood sugar tested to monitor any development of Type 2 diabetes.

The FDA will also place a notice on the label of statin medications that they may cause a cognitive impairment. In particular, confusion, forgetfulness, and memory loss has been indicated by some users of statins. Some users report having a fuzzy type of feeling with regard to their thinking.

In addition, we will see information on some statin labels that it can lead to muscle damage.

The FDA says that the new labels shouldn't cause people to fear taking statins. In some people, the benefits of taking the medications, significantly offset the side effects. And the benefits of statins in relation to heart disease have been proven. Therefore, patients will need to work with their doctors to find the best course of treatment for them.

Of course, it goes without saying to always check with your physician before starting or stopping any medication.